Insight

Anthony El-Khoueiry: Botensilimab with expansion in MSS CRC; activity noted across multiple cold tumors

Photo of Anthony El-Khoueiry taken from uscnorriscancer.usc.edu

Jun 15, 2024, 02:09

Anthony El-Khoueiry: Botensilimab with expansion in MSS CRC; activity noted across multiple cold tumors

Anthony El-Khoueiry, Associate Professor of Medicine at University of Southern California Norris Comprehensive Cancer Center, shared on LinkedIn:

“Honored to have served as lead investigator and co-senior corresponding author on this phase I study of botensilimab with expansion in MSS CRC; activity noted across multiple cold tumors.

Amazing collaboration with Agenus and all co-authors!

Thank you for the amazing support of our USC Norris Phase I Team!”

Proceed to the article.
Source: Anthony El-Khoueiry/LinkedIn

Agenus Anthony El-Khoueiry botensilimab cancer colorectal cancer MSS CRC Norris Comprehensive Cancer Center OncoDaily Oncology University of Southern California Norris Comprehensive Cancer Center

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Special Coverage